Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double-blind study.

Colwell CW Jr, Berkowitz SD, Davidson BL, Lotke PA, Ginsberg JS, Lieberman JR, Neubauer J, McElhattan JL, Peters GR, Francis CW.

J Thromb Haemost. 2003 Oct;1(10):2119-30.

2.
3.
4.

Clinical experience with ximelagatran in orthopaedic surgery.

Eriksson B.

Drugs. 2004;64 Suppl 1:27-35. Review.

PMID:
15586625
5.
6.

Ximelagatran--a promising new drug in thromboembolic disorders.

Petersen P.

Curr Pharm Des. 2005;11(4):527-38. Review.

PMID:
15725069
7.

Clinical experience of melagatran/ximelagatran in major orthopaedic surgery.

Eriksson BI.

Thromb Res. 2003 Jul 15;109 Suppl 1:S23-9. Review.

PMID:
12818631
8.

Ximelagatran for treatment and prophylaxis of recurrent events in deep vein thrombosis.

Koscielny J, Kiesewetter H, Jörg I, Harenberg J.

Clin Appl Thromb Hemost. 2007 Jul;13(3):299-307. Review.

PMID:
17636192
9.

Ximelagatran.

Choudhury A, Goyal D, Lip GY.

Drugs Today (Barc). 2006 Jan;42(1):3-19. Review.

PMID:
16511607
10.

Prevention of venous thromboembolism following orthopaedic surgery: clinical potential of direct thrombin inhibitors.

Eriksson BI, Dahl OE.

Drugs. 2004;64(6):577-95. Review. Erratum in: Drugs. 2004;64(8):912.

PMID:
15018589
11.
12.

The role of oral direct thrombin inhibitors in the prophylaxis of venous thromboembolism.

Hawkins D.

Pharmacotherapy. 2004 Oct;24(10 Pt 2):179S-183S. Review.

PMID:
15624337
13.

Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement.

Salazar CA, Malaga G, Malasquez G.

Cochrane Database Syst Rev. 2010 Apr 14;(4):CD005981. doi: 10.1002/14651858.CD005981.pub2. Review.

PMID:
20393944
14.

Ximelagatran: an orally active direct thrombin inhibitor.

Gulseth MP.

Am J Health Syst Pharm. 2005 Jul 15;62(14):1451-67. Review.

PMID:
15998925
15.

Fondaparinux for prevention of venous thromboembolism in major orthopedic surgery.

Tran AH, Lee G.

Ann Pharmacother. 2003 Nov;37(11):1632-43. Review.

PMID:
14565815
16.

A review of the oral direct thrombin inhibitor ximelagatran: not yet the end of the warfarin era...

Mohapatra R, Tran M, Gore JM, Spencer FA.

Am Heart J. 2005 Jul;150(1):19-26. Review.

PMID:
16084146
18.

Ximelagatran in orthopaedic surgery.

Eriksson B.

Pathophysiol Haemost Thromb. 2005;34 Suppl 1:10-7. Review.

PMID:
15812199
19.

Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery?

Strebel N, Prins M, Agnelli G, Büller HR.

Arch Intern Med. 2002 Jul 8;162(13):1451-6. Review.

PMID:
12090880
20.

Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair.

Forster R, Stewart M.

Cochrane Database Syst Rev. 2016 Mar 30;3:CD004179. doi: 10.1002/14651858.CD004179.pub2. Review.

PMID:
27027384
Items per page

Supplemental Content

Write to the Help Desk